Clearview Wealth Advisors LLC Corcept Therapeutics Inc Transaction History

Clearview Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	BUY	$21.1 - $27.46 $303,460 - $394,929	14,382 New	14,382 $362,000
Q3 2023 Oct 30, 2023	BUY	$21.97 - $33.8 $553,160 - $851,016	25,178 Added 31472.5%	25,258 $688,000
Q2 2023 Aug 07, 2023	SELL	$21.44 - $25.15 $733,140 - $860,004	-34,195 Reduced 99.77%	80 $1,000
Q1 2023 Apr 12, 2023	BUY	$19.2 - $24.47 $658,080 - $838,709	34,275 New	34,275 $742,000

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.